Natural bioactive compounds reprogram bile acid metabolism in MAFLD: Multi-target mechanisms and therapeutic implications
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114708 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Dongjie Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China. Hauptthemen laut MEDLINE: Bile Acids and Salts, Non-alcoholic Fatty Liver Disease, Biological Products, Drugs, Chinese Herbal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sanming Project of Medicine in Shenzen Municipality.
Abstract (Originalsprache)
Metabolic-associated fatty liver disease (MAFLD) has become an increasingly prevalent liver disorder worldwide, being closely associated with obesity, metabolic syndrome, and insulin resistance. Bile acids (BAs), beyond their traditional role in lipid digestion, play a pivotal part in regulating lipid and glucose metabolism as well as inflammatory responses. Recent investigations have recognized BAs as key factors in the onset and progression of MAFLD, mainly via their interactions with nuclear receptors such as the farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor (TGR5). Additionally, active compounds derived from traditional Chinese medicine (TCM) have shown promising potential in the treatment of MAFLD. This study systematically reviews and analyzes the molecular mechanisms and recent progress in the application of TCM active ingredients for MAFLD treatment, with a focus on their regulation of BAs. These active ingredients, including saponins, flavonoids, polysaccharides, and sterols, exert therapeutic effects through diverse mechanisms, such as modulating BA synthesis and mediating receptor-signaling pathways, and are expected to restore metabolic homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infection, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
- Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
- Department of Traditional Chinese Medicine, Peking University People's Hospital, Beijing 100044, China.
- Department of Infection, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China. Electronic address: 18253199390@163.com.
- Department of Hepatology, Shenzhen Bao'an District Traditional Chinese Medicine Hospital, Shenzhen 518100, China. Electronic address: 15920089572@163.com.
- Department of Infection, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China. Electronic address: lvwenliang@sohu.com.
Förderung
- National Natural Science Foundation of China
- Sanming Project of Medicine in Shenzen Municipality
Zitieren
APA
Wu, D., Liu, J., Guo, Z., Wang, L., Yao, Z., Wu, Q., Lu, Y., & Lv, W. (2025). Natural bioactive compounds reprogram bile acid metabolism in MAFLD: Multi-target mechanisms and therapeutic implications. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114708
Vancouver
Wu D, Liu J, Guo Z, Wang L, Yao Z, Wu Q, et al. Natural bioactive compounds reprogram bile acid metabolism in MAFLD: Multi-target mechanisms and therapeutic implications. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114708
BibTeX
@article{Wu2025,
author = {Wu, Dongjie and Liu, Jing and Guo, Ziwei and Wang, Liang and Yao, Ziang and Wu, Qingjuan and Lu, Yanping and Lv, Wenliang},
title = {Natural bioactive compounds reprogram bile acid metabolism in MAFLD: Multi-target mechanisms and therapeutic implications},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114708}
}
EUVIMED